| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13K | — |
| Cost of Revenue | $7K | — |
| Gross Profit | $7K | — |
| R&D Expense | $3.4M | +44.1% |
| SG&A Expense | $9.5M | -13.0% |
| Operating Income | -$12.9M | +2.8% |
| Pre-tax Income | -$41.0M | -58.1% |
| Net Income | -$41.0M | -58.1% |
| EPS (Basic) | -$10.39 | -3896.2% |
| EPS (Diluted) | -$10.39 | -3896.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $205K | -93.9% |
| Accounts Receivable | $5K | +411.5% |
| Inventory | $24K | +0.0% |
| Current Assets | $783K | -79.9% |
| Total Assets | $4.8M | -39.7% |
| Total Liabilities | $12.0M | -61.2% |
| Stockholders' Equity | -$7.2M | +68.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.5M | +38.5% |
| Capital Expenditures | $118K | — |
| Investing Cash Flow | -$241K | +2.2% |
| Financing Cash Flow | $1.6M | -85.2% |
| Free Cash Flow | -$4.7M | — |